Brecklandscientific.co.uk
Revision date 08-04-2016
Section 1: Identification of the substance/ mixture and of the company/ undertaking.
1.1 Product identifier
1.2 Relevant identified uses of the substances or mixture and uses advised against
Laboratory chemicals, manufacture of substances, Scientific R&D
1.3 Details of the supplier of the safety data sheet
Breckland Scientific Supplies Ltd
Antom Court, Tollgate Drive, Stafford, ST16 3AF
Emergency telephone
08:30-17:00 01785 227227
Section 2: Hazards identification
2.1 Classification of the substance or mixture
2.1.1 Classification -
Xn; R22 Acute Tox. 4 Harmful
2.1.2 Classification – EC
2.2 Label elements
Revision date 08-04-2015
Hazard Pictograms
Hazard statement
H302: Harmful if swallowed.
Precautionary statement
P301+P312: IF SWALLOWED: Call a POISON CENTER or doctor/physician if you feel unwell.
Section 3: Composition/information on ingredients
67/548/EEC/1999/45/EC
S No. EINECS No.
58-08-2 200-362-1 H302
S No. EINECS No.
58-08-2 200-362-1 Xn; R22 Acute Tox. 4
Section 4: First aid measures
4.1 Description of first aid measures
Move the exposed person to fresh air. If breathing stops, provide artificial respiration.
Rinse immediately with plenty of water for 15 minutes holding the eyelids open. Seek medical attention.
Remove all contaminated clothes and footwear immediately unless stuck
to skin. Wash off immediately with plenty of soap and water. Seek medical attention if irritation or symptoms persist.
DO NOT INDUCE VOMITING. Never give anything by mouth to an
unconscious person. Rinse mouth thoroughly. Seek medical attention.
General information:
If you feel unwell, seek medical advice (show the label where possible).
Section 5: Firefighting measures
Revision date 08-04-2015
5.1 Extinguishing media
Use extinguishing measures that are appropriate to local
circumstances and the surrounding environment
5.2 Special hazards arising from
No data available
substances or mixture 5.3 Advice for firefighters
Wear suitable respiratory equipment when necessary
Section 6: Accidental release measures
Wear suitable protective clothing. Avoid breathing
6.1 Personal precaution,
vapours, mist or gas. Avoid formation of dust. Ensure
protective equipment and
adequate ventilation of the working area. Evacuate
emergency procedures
personnel to a safe area.
Prevent further spillage if safe. Do not allow product to enter
6.2 Environmental precautions
Avoid raising dust. Sweep up. Transfer to suitable, labelled
6.3 Methods and materials for
containments and cleaning up
containers for disposal.
Section 7: Handling and storage
7.1 Precautions for safe handling
Handle in accordance with good industrial hygiene and safety practice. Avoid formation of dust. Ensure adequate ventilation of the working area.
7.2 Conditions for safe storage
Store in a cool, dry area. Keep container tightly closed.
including any incompatibilities.
Section 8: Exposure controls/ personal protection
8.1 Control parameters
8.1.1 Exposure limit values
Long Term (8hr TWA)
Short term (15min period STEL)
CAS No: 58-08-2 ppm
Revision date 08-04-2015
8.2 Exposure controls
Appropriate engineering
Handle in accordance with good industrial hygiene and safety
practice. Wash hands before breaks and at the end of the working day. Ensure adequate ventilation of the working area.
Eye/ face protection
Approved safety glasses. Face shield where appropriate.
Skin/ hand protection
Wear suitable protective clothing and gloves.
Respiratory protection
Where risk assessment shows it is necessary, use a dust mask type
or breathing apparatus.
Section 9: Physical and chemical properties
9.1 Information on basic physical and chemical properties
Melting point oC:
Boiling point oC:
No data available
Relative density g/cm3:
Chemical formula:
C₈H₁₀N₄O₂
Molecular weight g/mol:
Section 10: Stability and reactivity
No data available
10.2 Chemical stability
Stable under normal conditions
10.3 Possibility of hazardous reactions
No data available
10.4 Conditions to avoid
No data available
10.5 Incompatible materials
No data available
10.6 Hazardous decomposition products
No data available
Section 11: Toxicological information
11.1 Information on toxicological effects: Acute toxicity
No data available
Germ cell mutagenicity
No data available
No data available
Reproductive toxicity
No data available
11.4 Toxicological information Caffeine
Oral Rat LD50 mg/kg: 367.7
Section 12: Ecological information
Revision date 08-04-2015
Toxicity to daphnia and other aquatic vertebrates
EC50 Daphnia magna: 182
(Water flea) mg/l - 48hr
Section 13: Disposal considerations
General information
Dispose of in compliance with all local and national regulations.
Disposal methods
Contact a licensed waste disposal company. Dispose of this
material and its container to hazardous or special waste collection point
Section 14: Transport information
14.1. UN Number:
14.2 UN Proper shipping name: Caffeine
14.3. Transport hazard class(es): 8
14.4. Packing group: II
14.5 Environmental hazards:
ADR/RID: no IMDG Marine pollutant: no IATA: no
Section 15: Regulatory information
15.1 Safety, health and environmental regulations/ legislation specific for the substance or mixture
Labelling according to Regulation (EC) No 1272/2008.
Section 16: Other information
16.1: Other information
Text of risk phrases in Section 3 Xn; R22 Acute Tox. 4 Harmful
Harmful if swallowed.
Revision date 08-04-2015
Text of hazard statements in Section 3 H302
Harmful if swallowed.
16.2 Further information
The information supplied in this Safety Data Sheet is designed only as guidance
for the safe use, storage and handling of the product. This information is correct to the best of our knowledge and belief at the date of publication however no guarantee is made to its accuracy. This information relates only to the specific material designated and may not be valid for such material used in combination with any other materials. Breckland Scientific Supplies Limited will not be held liable for any damage or injury caused by this product and does not obviate the requirement for end users to carry out their own workplace and specific use risk assessment.
Source: http://www.brecklandscientific.co.uk/v/vspfiles/MSDS/S6101548.pdf
INTRODUCTORY BROCHURE The DoseMe Platform The DoseMe® Platform Personalised Medicine: Making Complex Simple What is DoseMe®?DoseMe is an easy-to-use Bayesian dose-individualisation platform designed for clinicians and healthcare practitioners to optimise patient care. DoseMe currently supports several classes of drugs, including antibiotics, anti-coagulants, and
Implantable Cardioverter-Defibrillator Efficacy in Patients With Heart Failure and Left Ventricular Dysfunction (from the MADIT II Population) Wojciech Zareba, MD, PhD, Katarzyna Piotrowicz, MD, Scott McNitt, MS, and Arthur J. Moss, MD, for the MADIT II Investigators The Multicenter Automatic Defibrillator Implantation The Multicenter Automatic Defibrillator Trial II